Moreover, Bradwejn et al. subsequently performed dose ranging studies [54], showing that panic disorder patients have an increased sensitivity to CCK-4, and examined the therapeutic effect of CCK2-receptor antagonists (also including L-365, 260) [55]. This evidence concerns the gene CCKBR and panic disorder.